These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18279732)

  • 1. Percutaneous coronary intervention pharmacology: from a triangle to a square.
    Dauerman HL
    J Am Coll Cardiol; 2008 Feb; 51(7):698-700. PubMed ID: 18279732
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and tolerability of hirudins in percutaneous coronary intervention and the risk of Kounis syndrome.
    Kounis NG; Kounis SA; Kounis GN; Hahalis G
    Catheter Cardiovasc Interv; 2009 Mar; 73(4):584-5. PubMed ID: 19085914
    [No Abstract]   [Full Text] [Related]  

  • 3. [Coronary disease: therapeutic gains].
    Vogt P
    Rev Med Suisse Romande; 1999 May; 119(5):367-71. PubMed ID: 10384770
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antithrombotic therapy in coronary intervention: angioplasty and coronary bypass surgery].
    Kornowski R; Schwartz D; Aderka D; Levo Y
    Harefuah; 1991 Jul; 121(1-2):51-4. PubMed ID: 1748346
    [No Abstract]   [Full Text] [Related]  

  • 5. [The diagnosis and treatment of coronary heart disease in chronic renal failure].
    Belialov FI
    Klin Med (Mosk); 2004; 82(10):8-12. PubMed ID: 15584591
    [No Abstract]   [Full Text] [Related]  

  • 6. [Percutaneous coronary intervention in patients with multiple diseases is not evidence-based. Risk of increasing long-term mortality because of indication sliding].
    Bjessmo S; Van der Linden J; Kjellman U
    Lakartidningen; 2007 Jun 4-11; 104(23):1780-2. PubMed ID: 17655021
    [No Abstract]   [Full Text] [Related]  

  • 7. Pericardial patch on coronary aneurysm.
    Nakamura T
    Ann Thorac Surg; 2009 Jan; 87(1):351; author reply 351-2. PubMed ID: 19101341
    [No Abstract]   [Full Text] [Related]  

  • 8. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
    Rubboli A; Halperin JL
    Thromb Haemost; 2008 Nov; 100(5):752-3. PubMed ID: 18989515
    [No Abstract]   [Full Text] [Related]  

  • 9. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.
    Roldán V; Marín F
    Thromb Haemost; 2008 Nov; 100(5):754-5. PubMed ID: 18989516
    [No Abstract]   [Full Text] [Related]  

  • 10. Hemorrhagic complications in association with percutaneous coronary intervention: can the risk be attenuated?
    Feit F; Bittl JA; Keller NM; Attubato MJ; Weitz JI
    J Invasive Cardiol; 2000 Dec; 12 Suppl F():7F-13. PubMed ID: 11156728
    [No Abstract]   [Full Text] [Related]  

  • 11. Gastrointestinal bleeding in percutaneous coronary intervention and acute coronary syndromes.
    Nikolsky E; Mehran R; Stone GW
    Am J Cardiol; 2009 Sep; 104(5 Suppl):22C-9C. PubMed ID: 19695357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The importance of the knowledge of acute coronary syndrome].
    Horváth I; Cziráki A; Papp L
    Orv Hetil; 2005 May; 146(20 Suppl 2):1068-74. PubMed ID: 15945235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart lines. Angioplasty versus clot busters for older heart-attack patients.
    Harv Heart Lett; 1999 Nov; 10(3):6-7. PubMed ID: 10521936
    [No Abstract]   [Full Text] [Related]  

  • 14. Tug of war.
    Manoukian SV
    Am J Cardiol; 2009 Sep; 104(5 Suppl):1C-3C. PubMed ID: 19695353
    [No Abstract]   [Full Text] [Related]  

  • 15. Hemophilia and percutaneous coronary interventions.
    Mafrici A; Baudo F
    Ital Heart J; 2003 Oct; 4(10):731-3. PubMed ID: 14664289
    [No Abstract]   [Full Text] [Related]  

  • 16. "Triple therapy" or triple threat? Balancing the risks of antithrombotic therapy for patients with atrial fibrillation and coronary stents.
    Francescone S; Halperin JL
    J Am Coll Cardiol; 2008 Feb; 51(8):826-7. PubMed ID: 18294567
    [No Abstract]   [Full Text] [Related]  

  • 17. Anaemia as predictor of gastrointestinal bleeding in atrial fibrillation patients undergoing percutaneous coronary artery stenting.
    Manzano-Fernández S; Marin F; Martinez JA; Cambronero F; Valdés M; Ruiz-Nodar JM; Pérez-Berbel P; Lip GY
    QJM; 2008 Sep; 101(9):749-51. PubMed ID: 18664533
    [No Abstract]   [Full Text] [Related]  

  • 18. Improving long-term outcomes of coronary intervention in patients with diabetes.
    Shen WF
    Chin Med J (Engl); 2009 Mar; 122(6):605-7. PubMed ID: 19323918
    [No Abstract]   [Full Text] [Related]  

  • 19. Recommendations regarding stent selection in relation to the timing of noncardiac surgery postpercutaneous coronary intervention.
    Satler LF
    Catheter Cardiovasc Interv; 2004 Oct; 63(2):146-7. PubMed ID: 15390238
    [No Abstract]   [Full Text] [Related]  

  • 20. [Antithrombotic treatment after coronary stenting in patients with an indication to oral anticoagulation: what are the possible strategies?].
    Rubboli A; Di Pasquale G
    G Ital Cardiol (Rome); 2006 Jan; 7(1):68-73. PubMed ID: 16528965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.